Hedge Fund - Caligan Partners
Anika Therapeutics Inc. (ANIK)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $21,570,004 | 4.5% | 1,435,130 | $16.64 |
| 2 | 2024 - Q4 (2024-12-31) | $23,622,240 | 5.98% | 1,435,130 | $19.72 |
| 3 | 2024 - Q3 (2024-09-30) | $35,447,711 | 11.24% | 1,435,130 | $25.93 |
| 4 | 2024 - Q2 (2024-06-30) | $36,373,703 | 8.5% | 1,435,993 | $25.92 |
| 5 | 2024 - Q1 (2024-03-31) | $36,474,222 | 9.64% | 1,435,993 | $24.20 |
| 6 | 2023 - Q4 (2023-12-31) | $24,503,618 | 8.26% | 1,081,360 | $20.69 |
| 7 | 2023 - Q3 (2023-09-30) | $20,145,737 | 9.25% | 1,081,360 | $20.74 |
| 8 | 2023 - Q2 (2023-06-30) | $18,713,160 | 10.52% | 720,291 | $26.76 |
| 9 | 2023 - Q1 (2023-03-31) | $20,543,158 | 14.32% | 715,291 | $29.76 |
| 10 | 2022 - Q4 (2022-12-31) | $17,513,580 | 14.57% | 591,675 | $28.44 |
The displayed share prices are average quarterly stock market prices.